KMT2A rearrangements occur as the initial or unique genetic lesion in >75% of infants with B-ALL and rarely in children and adults, producing leukemia with mixed myeloid and B-lymphoid characteristics and a uniformly worse prognosis (40). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.